Search for grants with us!
Grants you might be eligible for
Investigate Quantum Sensing and Computing Applied to ATM
HORIZON-SESAR-2025-DES-ER-03
Programme: Horizon Europe
GRANT OVERVIEW
ELIGIBILITY CRITERIA
Funding
Up to 1000000.00 EUR
Deadline
Sept. 15, 2025, 10 p.m.
Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders
RFA-DA-25-073
Programme: NIH Research Project Grant
General Overview
Organizational Aspects
Up to 700000.00 USD
July 14, 2025, 5 p.m.
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
PAR-23-311
Programme: NIH SBIR/STTR Program
Up to 1972828.00 USD
Sept. 5, 2026, 9 p.m.
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders
PAR-23-021
Programme: NIH Director’s Pioneer Award (NDPA)
Up to 300000.00 USD
Sept. 25, 2025, 10 p.m.
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
PAR-23-084
Up to None USD
Jan. 13, 2026, 10 p.m.
Limited Competition: National Primate Research Centers (P51)
PAR-23-126
Programme: NIH Research Infrastructure Programs
May 25, 2026, 10 p.m.
Instrumentation Grant Program for Resource-Limited Institutions
PAR-23-138
Programme: Instrumentation Grant Program
Up to 250000.00 USD
July 4, 2025, 10 p.m.
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans Required)
PAR-23-158
Programme: NIH Grants
Up to 500000.00 USD
March 13, 2026, 10 p.m.
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes
PAR-22-131
Programme: NIH Research Project Grant (R01)
Sept. 8, 2025, 10 p.m.
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
PA-23-317
Nov. 24, 2026, midnight
Commercial Fishing Occupational Safety Training Project Grants (T03)
RFA-OH-22-006
Programme: CDC Grants
Up to 975000.00 USD
Jan. 26, 2027, 10 p.m.
HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services
RFA-DA-24-067
Programme: NIH HEAL Initiative
Up to 800000.00 USD
Jan. 16, 2026, 5 p.m.
High Priority HIV and Substance Use Research
RFA-DA-25-060
Up to 1500000.00 USD
Feb. 11, 2027, 10 p.m.
Administrative Supplements to Existing NIH Grants and Cooperative Agreements
PA-20-272
Sept. 30, 2025, midnight
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research
PAR-24-089
Programme: NIDA Mentored Clinical Scientist Development Program
Up to 750000.00 USD
Nov. 13, 2026, 10 p.m.
University Nuclear Leadership Program (UNLP) Scholarship and Fellowship
UNLP
Programme: Nuclear Energy University Program
Oct. 14, 2030, midnight
NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
PAR-24-200
Programme: NIH Research Education Program (R25)
July 15, 2026, 10 p.m.
Small Business Transition Grant for New Entrepreneurs
PAR-24-134
Programme: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR)
Up to 2045816.00 USD
April 6, 2027, 10 p.m.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
RFA-CA-25-007
Programme: NCI IMAT program
Up to 150000.00 USD
Oct. 3, 2025, 9 p.m.
466 results. Page 20 of 24.